DBV Technologies (DBVT) Net Cash Flow (2020 - 2026)

DBV Technologies (DBVT) posted quarterly Net Cash Flow of -$53.1 million for Q2 2026, down 163.9% year-on-year from $83.1 million in Q2 2025, and down 234.43% on a QoQ basis from $39.5 million in Q1 2026.

DBV Technologies (DBVT) Net Cash Flow (2020 - 2026) Analysis & Trends

DBV Technologies (DBVT) has reported Net Cash Flow for 7 consecutive years, with -$53.1 million the latest figure, recorded in Q2 2026.

  • Quarterly Net Cash Flow fell 163.9% year-over-year to -$53.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $77.0 million (up 159.74% YoY) and the FY2025 annual result came in at $153.6 million, up 246.81% from the prior year.
  • Net Cash Flow slipped to -$53.1 million in Q2 2026 per DBVT's latest filing, from $39.5 million in the prior quarter.
  • Over the last five years, Net Cash Flow for DBVT reached as high as $184.9 million in Q2 2022 and fell as low as -$53.1 million in Q2 2026.
  • A 5-year average of $5.6 million and a median of -$20.4 million in 2022 frame the typical range for Net Cash Flow.
  • Annual changes were most pronounced in 2023 — Net Cash Flow slumped 1200.0% — and 2025, when it soared 1242.17%.
  • Year by year, Net Cash Flow stood at -$24.2 million in 2022, then surged by 41.9% to -$14.1 million in 2023, then increased by 23.31% to -$10.8 million in 2024, then surged by 1242.17% to $123.2 million in 2025, then sank by 143.11% to -$53.1 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods registered -$53.1 million, $39.5 million, and $123.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 10.56 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 224.46 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.34 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 457.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -152.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 57.19 Mn
10 DBV Technologies 267.50 Mn 92.60 Mn - -53.10 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -53.10 Mn
Jun 30, 2026 -53.10 Mn
Mar 31, 2026 39.50 Mn
Mar 31, 2026 39.50 Mn
Dec 31, 2025 123.17 Mn
Dec 31, 2025 123.17 Mn
Sep 30, 2025 -32.54 Mn
Sep 30, 2025 -32.54 Mn
Jun 30, 2025 83.10 Mn
Jun 30, 2025 83.10 Mn
Mar 31, 2025 -20.10 Mn
Mar 31, 2025 -20.10 Mn
Dec 31, 2024 -10.78 Mn
Dec 31, 2024 -10.78 Mn
Sep 30, 2024 -22.56 Mn
Sep 30, 2024 -22.56 Mn
Jun 30, 2024 -34.42 Mn
Jun 30, 2024 -34.42 Mn
Mar 31, 2024 -36.89 Mn
Mar 31, 2024 -36.89 Mn